Losartan, an angiotensin II type 1 receptor blocker, protects human islets from glucotoxicity through the phospholipase C pathway

  • A.-M. Madec, R. Cassel, S. Dubois, S. Ducreux, G. Vial, M.-A. Chauvin, A. Mesnier, K. Chikh, D. Bosco, J. Rieusset, F. Van Coppenolle, C. Thivolet
  • The FASEB Journal, September 2013, Federation of American Societies For Experimental Biology (FASEB)
  • DOI: 10.1096/fj.13-234104

The authors haven't yet claimed this publication.

Read Publication